Publications by authors named "Steve Quessy"

Claim this Profile
S
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting.
R Andrew Moore, Philip J Wiffen, Christopher Eccleston, Sheena Derry, Ralf Baron, Steve N Quessy

Pain· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How should we interrogate the ClinicalTrials.gov database?
Steve N Quessy

J Pain· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study selection criteria and the choices we make.
Steve N Quessy

Pain· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where are the new analgesics? An alternative approach to early phase analgesic trials using a multivariable input model with adaptively allocated enrichment.
Steve N Quessy

Pain· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges of translational research for analgesics: the state of knowledge needs upgrading and some uncomfortable deficiencies remain to be urgently addressed.
Steve N Quessy

J Pain· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, Ralf Baron, Nicholas Bellamy, Steve Quessy

Pain· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-stage enriched enrolment pain trials: a brief review of designs and opportunities for broader application.
Steve N Quessy

Pain· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled, dose-ranging study investigating single doses of GW406381, naproxen sodium, or placebo in patients with acute pain after third molar tooth extraction.
Julie Varner, Mark Lomax, David Blum, Steve Quessy

Clin J Pain· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
Steve Shackelford, Richard Rauck, Steve Quessy, David Blum, Rachel Hodge

J Pain· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Animal models and the prediction of efficacy in clinical trials of analgesic drugs: A critical appraisal and a call for uniform reporting standards.
Steve N Quessy

Pain· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies.
Diane J Boswell, Keld Ostergaard, Richard S Philipson, Rachel A Hodge, David Blum, Steve N Quessy

Medscape J Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.
Dennis C Turk, Robert H Dworkin, Michael P McDermott, Nicholas Bellamy, Laurie B Burke, Steve Quessy

Pain· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo response in neuropathic pain trials.
Steve N Quessy, Michael C Rowbotham

Pain· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, Kathleen W Wyrwich, Dorcas Beaton, Charles S Cleeland, Steve Quessy

J Pain· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.
Marianne Silver, David Blum, Joanne Grainger, Anne E Hammer, Steve Quessy

J Pain Symptom Manage· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.
Aaron I Vinik, Michael Tuchman, Beth Safirstein, Clinton Corder, Louis Kirby, Steve Quessy

Pain· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.
Dennis C Turk, Robert H Dworkin, Laurie B Burke, Richard Gershon, Margaret Rothman, Steve Quessy

Pain· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, John T Farrar, Jennifer A Haythornthwaite, Mark P Jensen, Steve Quessy

Pain· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model.
Mark S Wallace, Steve Quessy, Gery Schulteis

Pharmacol Biochem Behav· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.
Dennis C Turk, Robert H Dworkin, Robert R Allen, Nicholas Bellamy, Nancy Brandenburg, Steve Quessy

Pain· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain.
Mark S Wallace, Michael Rowbotham, Gary J Bennett, Troels S Jensen, Rosemarie Pladna, Steve Quessy

J Pain· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis